Pelotonia Institute for Immuno-Oncology
A comprehensive bench-to-bedside research initiative focused on harnessing the body’s immune system to fight cancer at all levels — from prevention to treatment and survivorship.
A comprehensive bench-to-bedside research initiative focused on harnessing the body’s immune system to fight cancer at a...
read moreCreating a new level of collaboration, research and discovery
- About
The PIIO is a comprehensive bench-to-clinical-trial research initiative that will accelerate advanced cellular therapies that harness the immune system to fight cancer.
- Is It Right for Me?
Here is what cancer patients should know about immuno-oncology before pursuing treatment.
- Centers of Research Excellence
Learn more about the research centers and team members that are part of the Pelotonia Institute for Immuno-Oncology.
- Advisory Boards
The Pelotonia Institute for Immuno-Oncology is comprised of both internal and external advisory boards.
- Administration
Get in touch with our administrative staff.
- Open Positions
The PIIO is seeking experienced tenure-track faculty (basic as well as clinical researchers).
- Membership Guidelines
View guidelines for becoming a member of the Pelotonia Institute for Immuno-Oncology.
- Membership Application
Apply to join our team at the Pelotonia Institute for Immuno-Oncology.
- Priority Research Voucher Program
Apply to receive funding from the Pelotonia Institute for Immuno-Oncology.
- Research and Clinical Trials
Learn more about the research and clinical trials being conducted through the Pelotonia Institute for Immuno-Oncology.
- News
View the latest for the Pelotonia Institute for Immuno-Oncology and immunotherapy.
- Strategic Plan
View the PIIO 2020-2025 Strategic Plan.
- IO Database
The Immune Oncology Retrospective Cohort Study is designed to promote immune-oncology and data science research.
- Annual Report
View and download the most recent PIIO Annual Report.
- Immuno-Oncology Informatics Group (IOIG)
A Pelotonia Institute for Immuno-Oncology Informatics Group dedicates to provide high-quality data analysis, tool development, statistical consultant, and trainings for immuno-oncology research.
- Immune Monitoring and Discovery Platform
Specialized research equipment that may even help researchers predict which patients will respond well to specific immuno-therapy drugs – based on their individual immune cell characteristics.
The Progress of the Pelotonia Institute for Immuno-Oncology, With Dr. Zihai Li
The James Cancer-Free World Podcast
"Immunotherapy holds the key for curing cancer," says Zihai Li, the founding director of the Pelotonia Institute for Immuno-Oncology. In this episode, Dr. Li provides an update on the important work of the institute, which has recruited 15 world-class cancer researchers in the past year, and describes two new genetic mutations that have been discovered — GARP and the hedgehog mutation — that hide cancer cells from the body's immune system. He also explains how immunotherapy drugs in development allow T cells and natural killer cells to detect and destroy cancer. "We're not there yet for every patient and every cancer, so we have a lot of work to do," Li says.
"Immunotherapy holds the key for curing cancer," says Zihai Li, the founding director of the Pelotonia Institute for Imm...
read moreBest and Brightest Minds in Immuno-Oncology
Learn more about some of the researchers behind the Centers of Research Excellence.
Zihai Li, MD, PhD
Systems Immuno-Oncology
Dr. Li is a member of the Translational Therapeutics Program at the OSUCCC – James and the founding director of the Institute for Immuno-Oncology (IIO), which is dedicated to transforming the OSUCCC – James into a leader in basic and clinical immunology research, including prevention and survivorship.
Elaine Mardis, PhD
Cancer Immuno-Genomics
Dr. Mardis focuses on systems immunology and immune-genomics.
Margaret Gatti-Mays, MD, MPH
Translational Immuno-oncology
Dr. Gatti-Mays specializes in side effects from immunotherapy and rare subtypes of breast cancer like small-cell breast cancer.
William Carson III, MD
Translational Immuno-oncology
Dr. Carson is a professor of surgery specializing in breast cancer, melanoma immunotherapy-myeloid derived suppressor cells or MDSCs.
Partner With the PIIO
The Pelotonia Institute for Immuno-Oncology is working to create a cancer-free world. Get involved today.
Get in Touch
Interested in collaborating on research or learning more? Contact the Pelotonia Institute for Immuno-Oncology today.
Contact UsJoin our team
The OSUCCC – James is seeking experienced tenure-track faculty (basic as well as clinical researchers) to work in the Pelotonia Institute for Immuno-Oncology.
Open Positions